Silver Spring, Md. - The FDA Dermatologic and Ophthalmic AdvisoryCommittee, by an 8-2 vote, on May 23 recommended approval of alefacept,a systemic drug for the treatment of chronic plaque psoriasis.
Skin Swab Analysis Reveals Early Predictors of Atopic Dermatitis in Infants
ReV Up Your Vitiligo Treatment Strategies
Reviewing Late-Breaking Research From AAD 2024
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
Amy Spizuoco, DO, FAOCD: Addressing STDs and Utilizing Dermatopathology With Care in Diverse Patient Populations
Pointers With Portela: Providing Free Dermatologic Care